Abstract:OBJECTIVE:To confirm Tanshinone II A's (Tan II A) anti-cancer activity on nude mice bearing human breast cancer cells with estrogen receptor (ER) positive and negative and to elucidate the mechanism of its activity in vivo. METHODS:Established the animal model of nude mices bearing human breast cell, both ER positive MCF-7 and ER negative MDA-MB-231, each group was divided into 3 subgroups, respectively by intraperitoneal injection of Tan II A at a dose of 30 mg/kg 4 times/week, by gavage of Tamoxifen at a dose of 1 mg/kg 7 times/ week and by solvent control for 4 weeks. All animals were tested for anti-cancer activity including the weights and the volumes of the tumor, apoptosis index by flow cytometry and expression of p53, bcl-2, cerbB-2 by immunohistochemistry method after the treatment. RESULTS:In MCF-7 group, there were a 33.64% tumor mass volume reduction and a 32.24% tumor mass weight reduction after Tan II A treatment; in MDA-MB-231 group, a 38.34% tumor mass volume reduction and a 39.82% tumor mass weight reduction were observed in Tan II A subgroups; the differences between Tan II A and Tamoxifen or solvent control were statistically significant in both groups (P < 0.05); increase of apoptosic fiction by flow cytometry examination in Tan II A subgroups in both MCF-7 (48.31% +/- 5.84%) and MDA-MB-231(50.25% +/- 5.03%) groups were observed, there were both significant differences between Tan II A and the other subgroups (P < 0.05). Statistically significant decrease of p53 and bcl-2 expression were observed in Tan lI A between solvent control subgroup in both MCF-7 and MDA-MB-231 groups (P < 0.05) while cerbB-2 had no significant difference with control group (P > 0.05). CONCLUSION:Tan lI A can inhibit both breast cancer cell MCF-7 and MDA-MB-231 growth in vivo, which had better anti-cancer effect than Tamoxifen. The mechanism may be associated with the induction of apoptosis, down regulation of the expression level of gene bcl-2 and p53, but may not with the expression level of cerbB-2.

Research Progress of Anticancer Effect of Tanshinone ⅡA in Vivo

[A Study on the Effect of Tanshinone II A Against Human Breast Cancer in Vivo].

[A Study on Anticancer Activity of Tanshinone II A Against Human Breast Cancer].

Effects of TanshinoneII-A on IL-6,IL-10 in RAW264.7 Cells

Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine.

Anticancer potential of Salvia miltiorrhiza and its tanshinones: an efficacy perspective

The Anticancer Properties of Tanshinones and the Pharmacological Effects of Their Active Ingredients

Research Progress of Pharmacologic Actions of Tanshinone ⅡA

Tanshinone IIA: A Review of its Anticancer Effects

Tanshinones: sources, pharmacokinetics and anti-cancer activities

Anticancer Effect of Tanshinones on Female Breast Cancer and Gynecological Cancer

Recent Research Progress (2015–2021) and Perspectives on the Pharmacological Effects and Mechanisms of Tanshinone IIA

Anti-migration and anti-angiogenic effects of tanshinone ⅡA on breast cancer cell MDA-MB435

The mechanisms of tanshinone in the treatment of tumors

The effect of Tanshinone II a on proliferation and apoptosis of human gastric adenocarcinoma cell line SGC-7901

Research and Development of Natural Product Tanshinone I: Pharmacology, Total Synthesis, and Structure Modifications

Research Progress of Tanshinones

An overview of the anti-cancer actions of Tanshinones, derived from Salvia miltiorrhiza (Danshen)

Growth Inhibition of Tanshinones on SPC-A-1 Cell Line and Their Structure-activity Relationship

Study on the Antitumor Mechanism of Tanshinone IIA In Vivo and In Vitro through the Regulation of PERK-ATF4-HSPA5 Pathway-Mediated Ferroptosis

The antitumor effect of tanshinone IIA on anti-proliferation and decreasing VEGF/VEGFR2 expression on the human non-small cell lung cancer A549 cell line